On This Day in Health: June 23, 1960
On June 23, 1960, Enovid became available in United States pharmacies for use as an oral contraceptive, bringing a new method of pregnancy prevention into medical practice. Manufactured by G. D. Searle, the medicine combined synthetic hormones that suppressed ovulation. Its arrival followed the FDA's earlier May announcement clearing contraceptive use; histories also identify June 23 with the formal authorization of its sale for that purpose. Those stages should be distinguished from the drug's earlier availability for menstrual disorders. The milestone made a daily prescription medicine a practical option for preventing pregnancy, rather than merely a promising result from laboratory and clinical research.
The development drew on years of hormone research, clinical testing and advocacy. Gregory Pincus and John Rock were central scientific and clinical figures, while Margaret Sanger promoted the goal and Katharine Dexter McCormick supplied crucial financial support. Trials, including studies in Puerto Rico, helped establish that a hormone regimen could prevent ovulation and pregnancy. The research also left difficult questions about how participants were informed and how their experiences were treated. These concerns belong alongside the scientific achievement. A medicine intended for widespread, continuing use by otherwise healthy people required careful consideration of safety as well as its ability to prevent conception.
Enovid had already received approval in 1957 for certain gynecological uses. The 1960 contraceptive indication changed what doctors could prescribe it for, but it did not instantly remove social and legal barriers. Patients still needed access to a prescriber, money to pay for the medicine and a setting where obtaining contraception was possible. Restrictions on contraceptive access persisted, particularly for unmarried people, and later court decisions altered that landscape. The first formulation also used higher hormone amounts than many later pills. Growing experience after approval brought greater attention to adverse effects, including the risk of blood clots, and helped drive changes in formulations and patient information.
The pill's longer influence extended into decisions about the timing of children, education, employment and family life. Those changes developed over years and depended on broader social conditions, rather than occurring automatically when a bottle reached a pharmacy counter. Nor did one oral medicine replace every other contraceptive method or suit every patient. June 23 nevertheless marks an important transition from research and regulatory review to an option that could be prescribed and purchased. Its legacy includes greater control over reproductive planning, continuing demands for equitable access and a lasting example of why successful innovation must be followed by careful monitoring and respect for the people who use it.
Enovid was a combined hormonal medicine manufactured by G. D. Searle. Its original 1957 approval concerned gynecological treatment, preceding authorization for contraceptive use.
The May 1960 clearance announcement and the June 23 sale milestone describe different stages. The anniversary concerns the pill's arrival as an available contraceptive, not the first discovery of reproductive hormones.
A prescription option could expand reproductive choice, but affordability, medical access and legal restrictions still shaped who could obtain it. Availability did not mean universal access.
Safety knowledge continued to develop after approval. The early high-hormone formulations and later evidence about clotting risks helped shape subsequent products and information for patients.
The pill influenced reproductive planning and women's opportunities over the following decades. Its effects interacted with legal and social changes rather than following from a single medical decision alone.
The history also includes the experiences of clinical-trial participants, including women in Puerto Rico. Informed consent, attention to adverse effects and respect for patients remain part of evaluating the achievement.
Explore more of "On This Day ..."
Discover more events from the same date across news, politics, technology, sports, and other fields. Each link highlights significant moments that shaped history on different fronts.